Term
Ischemia has 3 principal biochemical components: |
|
Definition
- Hypoxia (including andoxia)
- Insufficiency of metabolic substrates
- Accumulation of metabolic waste
|
|
|
Term
How do you differentiate between MI chest pain and angina chest pain? |
|
Definition
- When treated with nitroglycerin, MI chest pain does not go away immediately
- However, with angina, chest pain goes away immediately
|
|
|
Term
Echocardiogram is useful for determining: |
|
Definition
- Ejection Fraction (EF)
- Left Ventricular Hypertrophy
- Valve malformation or dysfunction
- Other structural problems
Echo is also a low risk procedure |
|
|
Term
Stable Angina Pectoris Risk Factors: |
|
Definition
- Male gender (2:1 men to women)
- Cigarette smoking
- High cholesterol levels (high LDL/low HDL)
- High BP
- Diabetes (impaired immune system)
- Family history of coronary heart disease before age 55
- Sedentary lifestyle
- Obesity
|
|
|
Term
Triggers for anginal chest pain: |
|
Definition
- Exercise
- Eating
- Emotional Stress
- Sex
- Cold temps
|
|
|
Term
Who gets Variant (Prinzmetal's) Angina? |
|
Definition
- Younger patients
- People with fewer coronary risk factors
- Smokers
|
|
|
Term
Surgical Interventions for Angina |
|
Definition
- Coronary Artery Bypass Graft (CABG)
- Percutaneous Transluminal Coronary Angioplasty (PTCA)
- Direct Coronary Atherectomy (DCA): plaque is mechanically removed
- Stens:
|
|
|
Term
Comparison of CABG and PCTA |
|
Definition
- CABG more invasive than PCTA
- CABG is higher risk than PCTA
- CABG is longer lasting/More likely to have follow-up procedures with PCTA
- CABG reduces symptoms better than PCTA
- CABG is strongly preferred in diabetic patients/PCTA is not useful in diabetic patients
- CABG may also be used to improve LV function
- PCTA may be used in combination with stents and drug-stents
- PCTA is best suited for new onset symptoms with large-artery stenosis
|
|
|
Term
Medication overview for angina: Symptomatic Relief |
|
Definition
- NTG and nitrates
- CCB (non-DHP)
|
|
|
Term
Medication overview for angina: Improve Longevity |
|
Definition
- Aspirin
- Clopidogrel
- Statins
|
|
|
Term
Medication overview for angina: For symptomatic relief and improve longevity |
|
Definition
|
|
Term
First line therapy for stable angina: |
|
Definition
|
|
Term
Most effective agent at reversing cardiac ischemia in patients with stable angina: |
|
Definition
|
|
Term
Goal for Beta-Blockers use in stable angina: |
|
Definition
Reduce HR to 50-60 BPM and exercise HR to 100 BPM |
|
|
Term
Treatment of choice for current anginal chest pain: |
|
Definition
|
|
Term
What is Nitrate Tolerance and how do you prevent it? |
|
Definition
- Nitrate tolerance leads to loss of efficacy of drug
- Classic presentation of nitrate tolerance is it works for 2 weeks for the patient but then angina attacks start to reappear
- All patients must have an 8-12hr nitrate-free period to avoid tolerance
- Patch: 12-14hrs per day off the patch
- Dinitrate: if TID, it should be AC
- Ointments: BID at most
- IR Mononitrate: should be 7am, 3pm (or equivalent)
- SR Mononitrate: Q24hrs
|
|
|
Term
|
Definition
- Indicated for those with angina and either diabetes or LVH
- ACEI definitely make you live longer if you have diabetes or LVH
- May or may not improve mortality in those without these other conditions
|
|
|
Term
For angina, CCB's are indicated for: |
|
Definition
- Those with contraindications to Beta-Blockers (COPD, pulmonary disease)
- Those with atrial arrhythmias (Non-DHP only)
- Prinzmetal's Angina (DHP)
- In combo with Beta-Blockers for additional benefit (monitor very closely)
|
|
|
Term
|
Definition
- Cause arterial dilation (all) and reduces HR (Non-DHP)
- Can inhibit coronary vasospasm
|
|
|
Term
|
Definition
- 1st agent in novel class: partial fatty-acid oxidation (PFox) inhibitors
- Will reduce myocardial oxygen demand by reducing metabolism
- Only indicated for those with stable angina who continue to have symptoms with standard therapy
- It is NOT a treatment for acute symptoms
- Do not take with grapefruit choice
- Potential for adverse effects associated with QT prolongation
- Less effective in women than in men
|
|
|
Term
Statins/Lipid therapy for patients with stable angina: Goals and Treatment |
|
Definition
If LDL is between 100-129mg/dL:
modify their lifestyle, receive drug therapy, or both to achieve an LDL cholesterol level of <100mg/dL
If LDL is >130:
patient should receive drug therapy to reduce the level to less than 100mg/dL
- If you can get patient to 100 easily, you should try to get them down to 70
- If Framingham Score is above 10%, you should get them down to 70
|
|
|
Term
Aspirin: Dose and Contraindications |
|
Definition
- All patients with angina should receive aspirin unless absolutely contraindicated
Dose: 70-161mg/day
Contraindications:
- acute liver disease
- true aspirin allergy
- aspirin trigger for pulmonary disease
- recent GI bleed
|
|
|
Term
Treatment of Prinzmetal's Angina |
|
Definition
- CCB (DHP and Non-DHP) are first line therapy
- Nitrates are useful to treat symptoms and as adjuncts to CCB as prophylaxis
- Combo of DHP and Non-DHP may be useful if solo agents fail
- Beta-blockers are not useful (may cause vasoconstriction of the arteries)
|
|
|
Term
|
Definition
- Sex is a common trigger for angina and MI
- PDE5-Inhibitors are safe in controlled angina but NEVER with a nitrate
- Exercise tolerance must be assessed in angina patients before PDE5 inhibitors are prescribed
- HR-limiting agents should be considered for sexually active angina patients
- Risk for acute MI should be discussed with men and women with angina
|
|
|